GRAINGER (W.W.) INC. DL 1/ US3848021040 /
22.05.2024 08:01:46 | Diff. +3,80 | Volumen | Geld12:47:04 | Brief12:47:04 | Marktkapitalisierung | Dividendenr. | KGV |
---|---|---|---|---|---|---|---|
878,00EUR | +0,43% | 0 Umsatz: 0.00 |
878,60Geld Vol: 10 | 886,60Brief Vol: 10 | 43,25 Mrd.EUR | - | - |
Newsfile Corp
13:00
Flow Beverage Corp. to Present at Water Tower Research's Inaugural Consumer Products Virtual Investo...
GlobeNewswire
13:00
Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention
GlobeNewswire
13:00
Medicenna to Present Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming Sachs 10th Annual...
GlobeNewswire
13:00
Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-...
GlobeNewswire
13:00
Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for De...
GlobeNewswire
13:00
Will AI Make Leaders Obsolete? AIIR Teams Up with Microsoft and Wharton to Consider the Implications
GlobeNewswire
13:00
Atea Pharmaceuticals Presents New Data Showcasing Potential Best-in-Class Combination Profile of Bem...
GlobeNewswire
13:00
Nokia successfully completes acquisition of Fenix Group, accelerating U.S. strategy
GlobeNewswire
12:56
Gate.io Celebrates 11th Anniversary with Prize Activities and Vision for the Future
GlobeNewswire
12:55
Antion Biosciences announces development of safety-enhanced and off-the-shelf CAR T-cells for autoim...
Newsfile Corp
12:36
Early Leak Unveils Exciting Lineup of Speakers and Sponsors for ADFO Summit 2024
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite